Dr. Jon O. Ebbert, MD

Dr. Ebbert practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Ebbert's NPI, 1952388423, was assigned on December 27, 2005. Dr. Ebbert graduated from University of Minnesota Medical School in 1996. Dr. Ebbert holds Minnesota license 39763.

Dr. Ebbert's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Dr. Ebbert's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dr. Ebbert is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Ebbert to 1 more hospital, 3 medical groups, 1 clinical lab and 1 hospice, each named with a free account. Dr. Ebbert's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ebbert practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ebbert's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ebbert is licensed in Minnesota.

CMS data shows 297 Medicare services from Dr. Ebbert across 5 procedure codes in 2024, for 171 Medicare patients. Medicare paid $17,088 for them.

CMS counts 171 Medicare patients who saw Dr. Ebbert in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ebbert's median patient age at 67, with 50% women.

In 2024, Dr. Ebbert wrote 4,004 Medicare Part D claims for 513 patients. 86% of them were for generic drugs. CMS names the drug for 3,330 of them, across 89 drugs with 11 or more claims each, at $259,761 in total drug cost. In 2023, CMS named 3,782 claims across 92 drugs.

Dr. Ebbert accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ebbert as offering telehealth.

Dmand AI links 211 papers to Dr. Ebbert, published from 2007 to 2025. 2018 was the busiest year, with 14. The most frequent topics are Smoking Cessation, Tobacco Use Disorder and Smoking. Dr. Ebbert has published most often in Nicotine Tob Res. Dr. Ebbert's most frequent co-authors are Ryan T. Hurt, MD, Muhamad Y. Elrashidi, MD and Sarah Jean Crane, MD.

Dmand AI links Dr. Ebbert to 2 clinical trials. Conditions studied include Smoking Cessation, Weight Loss and Body Weight Changes. Mayo Clinic sponsors the most, 2.

CMS Open Payments shows 4 general payments to Dr. Ebbert from 3 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 60% of the total. Alnylam Pharmaceuticals Inc. paid the most, $4,945. It also lists 2 research payments totaling $1,560 in 2020.

Dr. Ebbert graduated from University of Minnesota Medical School in 1996.